Cargando…

Myositis interstitial lung disease and autoantibodies

The aim of this review is to examine and evaluate published literature associated with idiopathic inflammatory myopathies (IIM) and interstitial lung disease (ILD) based on myositis specific autoantibodies (MSA) and the potential clinical significance of each autoantibody subtype for the practicing...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaudhry, Shire, Christopher-Stine, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296774/
https://www.ncbi.nlm.nih.gov/pubmed/37384043
http://dx.doi.org/10.3389/fmed.2023.1117071
_version_ 1785063729199579136
author Chaudhry, Shire
Christopher-Stine, Lisa
author_facet Chaudhry, Shire
Christopher-Stine, Lisa
author_sort Chaudhry, Shire
collection PubMed
description The aim of this review is to examine and evaluate published literature associated with idiopathic inflammatory myopathies (IIM) and interstitial lung disease (ILD) based on myositis specific autoantibodies (MSA) and the potential clinical significance of each autoantibody subtype for the practicing clinician. The review is a comprehensive search of literature published in PubMed from the year 2005 and onward coinciding with the surge in the discovery of new MSAs. Additionally, we comment on recommended multidisciplinary longitudinal care practices for patients with IIM-ILD with regard to imaging and other testing. Treatment is not covered in this review.
format Online
Article
Text
id pubmed-10296774
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102967742023-06-28 Myositis interstitial lung disease and autoantibodies Chaudhry, Shire Christopher-Stine, Lisa Front Med (Lausanne) Medicine The aim of this review is to examine and evaluate published literature associated with idiopathic inflammatory myopathies (IIM) and interstitial lung disease (ILD) based on myositis specific autoantibodies (MSA) and the potential clinical significance of each autoantibody subtype for the practicing clinician. The review is a comprehensive search of literature published in PubMed from the year 2005 and onward coinciding with the surge in the discovery of new MSAs. Additionally, we comment on recommended multidisciplinary longitudinal care practices for patients with IIM-ILD with regard to imaging and other testing. Treatment is not covered in this review. Frontiers Media S.A. 2023-06-13 /pmc/articles/PMC10296774/ /pubmed/37384043 http://dx.doi.org/10.3389/fmed.2023.1117071 Text en Copyright © 2023 Chaudhry and Christopher-Stine. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Chaudhry, Shire
Christopher-Stine, Lisa
Myositis interstitial lung disease and autoantibodies
title Myositis interstitial lung disease and autoantibodies
title_full Myositis interstitial lung disease and autoantibodies
title_fullStr Myositis interstitial lung disease and autoantibodies
title_full_unstemmed Myositis interstitial lung disease and autoantibodies
title_short Myositis interstitial lung disease and autoantibodies
title_sort myositis interstitial lung disease and autoantibodies
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296774/
https://www.ncbi.nlm.nih.gov/pubmed/37384043
http://dx.doi.org/10.3389/fmed.2023.1117071
work_keys_str_mv AT chaudhryshire myositisinterstitiallungdiseaseandautoantibodies
AT christopherstinelisa myositisinterstitiallungdiseaseandautoantibodies